American Century Companies Inc T Scan Therapeutics, Inc. Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
BUY
$5.85 - $9.51 $91,236 - $148,317
15,596 Added 48.91%
47,481 $277,000
Q1 2024

May 14, 2024
BUY
$4.89 - $8.3 $51,687 - $87,731
10,570 Added 49.59%
31,885 $253,000
Q4 2023

Feb 13, 2024
BUY
$2.66 - $6.76 $56,697 - $144,089
21,315 New
21,315 $124,000
Q3 2023

Nov 13, 2023
BUY
$2.04 - $2.94 $39,192 - $56,483
19,212 New
19,212 $49,000

Others Institutions Holding TCRX

# of Institutions
93
Shares Held
42.3M
Call Options Held
0
Put Options Held
0
View Full List

About TScan Therapeutics, Inc.

TCRX Quotes by TradingView
  • Ticker TCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,929,800
  • Market Cap $45.6M
  • Description
  • TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell ...
More about TCRX
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email